Chemed Corporation

CHE·NYSE·Healthcare
Compare
548.64+14.99 (+2.81%)today
At close: Nov 4, 4:00 PM EST · May be delayed up to 15 min · USD
Pre-market553.50+4.86 (+0.89%)

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close533.65
Open545.00
Day range530.38550.31
52-week range365.21562.24
Off day high−0.30%
Off 52-week high−2.42%
Volume221.23K
Avg. volume (3M)152.94K
Market cap7.11B
EPS (TTM)20.88
Forward P/E19.70
P/E ratio (TTM)26.28
Dividend yield0.51% (2.80)
Beta (5Y)0.49
Shares outstanding12.96M
Short interest6.24% of float
Earnings dateOct 27, 2026
Analyst target617.00
Profit margin10.61%

Against its peers

Compare in full ›
CHE NHC HCSG THC CVSG.L CRRX.TO
Market cap 7.11B 3.33B 1.79B 23.26B 937.74M 215.66M
P/E (TTM) 26.3 23.9 17.9 8.5 58.6 8.3
Forward P/E 19.7 494.0 21.2 14.3 13.6 11.3
Price/book 8.3 3.0 3.4 4.3 3.4 2.0
Dividend yield 0.51% 1.26% — — 0.65% 2.59%
1-year change +27.42% +69.92% +51.83% +43.13% +15.67% −7.61%
Today +2.81% +3.19% +3.79% +9.58% +1.96% +1.19%

The closest companies by business and industry (Medical Care Facilities). Prices may be delayed up to 15 min.

Latest news

All CHE news ›
Multibagg AI·Positive

Natura Hue-Chem Open Offer Seeks 26% Stake at ₹42 a Share

Natura Hue-Chem Limited has received an open offer from Kanika Chahal and Anuj Chahal to acquire up to 10,77,778 shares, or 26% of voting equity, at ₹42 per share after the acquirers agreed to buy 6,43,600 shares from existing promoters on…

OFS
Seoul Economic Daily··3 outletsPositive

LG Chem Expands Rare Obesity Drug Deal to 1.15 Trillion Won

LG Chem expanded its bivamelagon licensing deal with Rhythm Pharmaceuticals to 1.15 trillion won, with record upfront payments of about 600 billion won. LG Chem (051910) has expanded the value of its licensing deal with U.S.-based Rhythm…

More from 2 other outlets
Markets Daily·Positive

Chemed (CHE) versus Its Competitors Head-To-Head Review

Posted by Danessa Lincoln on Nov 3rd, 2026 Chemed (NYSE:CHE – Get Free Report) is one of 233 public companies in the “Healthcare Providers & Services” industry, but how does it contrast to its peers? We will compare Chemed to related…

Seoul Economic Daily··4 outletsPositive

LG Chem Expands Obesity Drug Licensing Deal to $855 Million

Deal Value Grows From $305 Million to $855 Million Company to Receive $350 Million in Additional Upfront Payments Through 2029 Positive Phase 2 Results Clear Path to Phase 3 This Year LG Chem (051910.KS) has expanded the global licensing…

More from 3 other outlets
Resource Recycling·Negative

LYB looks to EU for chem recycling growth

LyondellBasell now expects to build its second chemical recycling plant, MoreTec-2, in Europe rather than the US, because of insufficient US regulatory support, executives said during the company’s third-quarter earnings call. The…

The Capitol Forum·Negative

Chemed: Georgia Inspectors Placed VITAS’s State Operation in ‘Immediate Jeopardy’ After Patients in Crisis Experienced Lengthy Wait Times; Managers Told Inspectors They Were Unaware of State’s One-Hour Response Rule

Chemed: Georgia Inspectors Placed VITAS's State Operation in ‘Immediate Jeopardy’ After Patients in Crisis Experienced Lengthy Wait Times; Managers Told Inspectors They Were Unaware of State's One-Hour Response Rule The Capitol Forum…

From the 4Search news index, newest first.

In the news

114mentions in 30 days
111with it in the headline
Positivesentiment

Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 114 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4SEARCH.business index. Terms of use. How to use Finance